GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are enclosing herewith the copy of Standalone and Consolidated un-audited financial results of the Company for the quarter and half year ended September 30, 2022 as published in the Newspaper - The Free Press Journal (English) and Navshakti (Marathi) on Wednesday, November 16, 2022 Request you to take the same on records. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
In compliance with Regulation 39 (3) of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, kindly note that the Company/RTA will issue the Letter of Confirmation in lieu of Duplicate Share Certificate to the following shareholder as per attachment. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Deviation Or Variation Or Utilization Of Funds Raised Under Preferential Issue - Regulation 32(1) Of SEBI (LODR) Regulations, 2015 For The Quarter Ended September 30, 2022
In compliance with the Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find attached the Statement of Deviation or Variation or Utilization of funds raised through Preferential Issue by the Company for the quarter ended September 30, 2022 as reviewed by the Audit Committee. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Outcome for Outcome Of Board Meeting Held On November 14, 2022
In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today, November 14, 2022 has inter alia considered and approved the following: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022. Copies of the following enclosed as Annexure- I Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022; Limited Review Report of the Statutory Auditors on aforesaid results. The meeting of Board commenced at 5.30 p.m. and concluded at 6.45 p.m GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Outcome Of Board Meeting Held On November 14, 2022
In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today, November 14, 2022 has inter alia considered and approved the following: i. Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022. Copies of the following enclosed as Annexure- I Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022; Limited Review Report of the Statutory Auditors on aforesaid results. The meeting of Board commenced at 5.30 p.m. and concluded at 6.45 p.m. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We wish to inform that the Company has appointed Mr. Sameer Sankhe as Chief Digital Officer. Press release announced for the same is enclosed herewith. The same is being disclosed as information though the same is not ascertained as material information as per the Company''s ''Policy for determination of materiality of events''. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Intimation for Intimation Of Board Meeting To Approve The Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2022.
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve the un-audited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2022. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
In compliance with Regulation 39 (3) of Securities and Exchange Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015 and as informed by the Registrar and Share Transfer Agent, intimation is hereby given regarding loss of share certificate(s) and issue of duplicate share certificate. Copy of the intimation received from the RTA is attached. Kindly take the same on your record. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Intimation Of The Grant Of Options Under Genesys ESOP Scheme- 2022
We would like to inform you that the Compensation Committee of the Board of Directors of Company, at its meeting held on October 18, 2022 has granted 1,95,000 stock options to its eligible employees, in terms of the Company's ESOP Scheme- 2022. One stock option grant represents one equity share of Rs. 5/- each of the Company. The aforesaid options were granted at exercise price of Rs.325 to Rs.500 per equity share, which is at discount of 9.12% to 40.93% to the closing price of the company's equity share on the BSE Ltd on October 17, 2022. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Vineet ChopraDesignation :- Company Secretary and Compliance Officer